Michelle Chu
Overview
Explore the profile of Michelle Chu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dopheide J, Roth W, Roth W, Chu M, Chu M
Am J Health Syst Pharm
. 2024 Sep;
82(6):265-284.
PMID: 39324566
Purpose: One-third to one-half of ambulatory care patients report insomnia. The objective of this clinical review is to detail the many causes and evidence-based treatment options for insomnia in outpatients...
2.
Chu M, Lou M, Wang M, Flores A
J Health Care Poor Underserved
. 2024 Aug;
35(3):866-879.
PMID: 39129607
Methods: A retrospective case-control study was performed in a safety-net clinic and consisted of the initial SGLT2i prescriptions group and the group without. The data from the electronic medical records...
3.
Barragan N, Chen S, Abraham J, Chu M, Kuo T
J Public Health Manag Pract
. 2024 Jul;
30:S130-S136.
PMID: 39041749
Demand for scaling and sustaining clinical services to improve health outcomes while minimizing costs is rising, particularly for patients dealing with major cardiovascular disease and stroke risk factors such as...
4.
Roth W, Dadiomov D, Chu M
Ther Adv Drug Saf
. 2023 Dec;
14:20420986231213173.
PMID: 38074415
Background: Quetiapine is an antipsychotic with dose-related receptor affinity, which is commonly prescribed by specialties outside of psychiatry. Quetiapine can have adverse effects including weight gain, hyperglycemia, and falls. Therefore,...
5.
Pajulas A, Fu Y, Cheung C, Chu M, Cannon A, Alakhras N, et al.
Mucosal Immunol
. 2023 May;
16(4):432-445.
PMID: 37172907
Allergic asthma is a chronic lung disease characterized by airway hyperresponsiveness and cellular infiltration that is exacerbated by immunoglobulin E-dependent mast cell (MC) activation. Interleukin-9 (IL-9) promotes MC expansion during...
6.
Chu M, Gao H, Esparza P, Pajulas A, Wang J, Kharwadkar R, et al.
Physiol Rep
. 2023 Feb;
11(3):e15600.
PMID: 36750205
Populations that are born and raised at high altitude develop under conditions of chronic developmental hypoxia (CDH), which results in pulmonary adaptations of increased lung volume and diffusion capacity to...
7.
Kharwadkar R, Ulrich B, Chu M, Koh B, Hufford M, Fu Y, et al.
J Immunol
. 2023 Jan;
210(5):537-546.
PMID: 36637217
CD4+ TH cells develop into subsets that are specialized in the secretion of particular cytokines to mediate restricted types of inflammation and immune responses. Among the subsets that promote development...
8.
Ulrich B, Kharwadkar R, Chu M, Pajulas A, Muralidharan C, Koh B, et al.
Sci Immunol
. 2022 Mar;
7(69):eabg9296.
PMID: 35302861
Asthma is a chronic inflammatory lung disease with intermittent flares predominately mediated through memory T cells. Yet, the identity of long-term memory cells that mediate allergic recall responses is not...
9.
Han X, Fox S, Chu M, McCombs J
J Health Econ Outcomes Res
. 2022 Feb;
9(1):11-19.
PMID: 35111866
Secondary prevention with lipid-lowering medications in patients with atherosclerotic cardiovascular disease (ASCVD) is known to reduce the risk of clinical events and death. Current guidelines codify recommendations for implementing secondary...
10.
Han X, McCombs J, Chu M, Dougherty J, Fox D
J Hypertens
. 2019 Jan;
37(6):1276-1284.
PMID: 30624365
Objectives: The 2017 American College of Cardiology/American Heart Association High Blood Pressure Guidelines lowered high blood pressure (BP) threshold, recommending earlier treatment to prevent cardiovascular disease. This study estimated the...